Healthcare · Theme
Lilly raised sales guidance for third time this year as Zepbound sales soar. Its stock is rallying.
+100
+50
0
−50
−100
Bullish
Bearish
Tue 27
Wed 28
Thu 29
Fri 30
Sat 31
Sun 1
Today
| Day | Score |
|---|---|
| Tue 27 | no data |
| Wed 28 | no data |
| Thu 29 | no data |
| Fri 30 | no data |
| Sat 31 | no data |
| Sun 1 | no data |
| Today | no data |
What this theme is about
The drugmaker continues to dominate the market for prescription weight-loss drugs in the U.S.
Summary drawn from the reporting itself by the Glideslope engine. No AI writing.
- Mood now
- +71.2
- Latest day
- —
- Stories
- 2
- Sources
- 2


